关注
Jonathan Ashley Jefferson
Jonathan Ashley Jefferson
在 u.washington.edu 的电子邮件经过验证
标题
引用次数
年份
Antibrush Border Antibody Disease: A Case Series
M Pengshung, V Charu, ML Troxell, S Akilesh, KD Smith, JA Jefferson
Kidney Medicine 6 (7), 100841, 2024
2024
Association of COVID-19 Versus COVID-19 Vaccination With Kidney Function and Disease Activity in Primary Glomerular Disease: A Report of the Cure Glomerulonephropathy Study
C Wang, DA Glenn, M Helmuth, AR Smith, AS Bomback, PA Canetta, ...
American journal of kidney diseases 83 (1), 37-46, 2024
52024
Management of Lupus Nephritis: New Treatments and Updated Guidelines
R Avasare, Y Drexler, DJ Caster, A Mitrofanova, JA Jefferson
Kidney360 4 (10), 1503-1511, 2023
52023
Repurposing drugs for diseases associated with podocyte dysfunction
SJ Shankland, JA Jefferson, O Wessely
Kidney International 104 (3), 455-462, 2023
12023
Age of onset and disease course in biopsy-proven minimal change disease: an analysis from the cure glomerulonephropathy network
DP Chen, ME Helmuth, AR Smith, PA Canetta, I Ayoub, K Mucha, ...
American journal of kidney diseases 81 (6), 695-706. e1, 2023
42023
Racial and Ethnic Disparities in Acute Care Utilization Among Patients With Glomerular Disease
JR Krissberg, MM O’Shaughnessy, AR Smith, ME Helmuth, S Almaani, ...
American journal of kidney diseases 81 (3), 318-328. e1, 2023
2023
Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis
LH Mariani, S Eddy, FM AlAkwaa, PJ McCown, JL Harder, V Nair, ...
Kidney international 103 (3), 565-579, 2023
342023
Immunology: News 2010. Foreword
A Chevailler, MN Kolopp-Sarda, J Hughes, A Jefferson, ...
Deakin University, 2023
2023
Accreditation: What you want to know-Abusus non tollit usum. An interview with Hélène Mehay (head of the human health section/COFRAC)
C Naudin, J Hughes, A Jefferson, E Raynaud De Mauverger, ...
Deakin University, 2023
2023
The Study Group for Autoimmune Diseases (GEAI) took off...
J Hughes, A Jefferson, E Raynaud De Mauverger, G Fernandez, I Lowy, ...
Deakin University, 2023
2023
Mission and 1-year outcomes of a cardiorenal subspecialty consultation service
N Bansal, N Arora, D Mariuma, JA Jefferson, K O’Brien, S Shankland
Kidney360 3 (4), 749-751, 2022
52022
A Diverse Spectrum of Immune Complex–and Complement-Mediated Kidney Diseases Is Associated With Mantle Cell Lymphoma
NK Andeen, S Abdulameer, V Charu, JE Zuckerman, M Troxell, ...
Kidney International Reports 7 (3), 568-579, 2022
32022
Multidimensional data integration identifies tumor necrosis factor activation in nephrotic syndrome: a model for precision nephrology
LH Mariani, S Eddy, FM AlAkwaa, PJ McCown, JL Harder, S Martini, ...
Medrxiv, 2021.09. 09.21262925, 2021
42021
Calculating estimated glomerular filtration rate without the race correction factor: observations at a large academic medical system
J Shi, EG Lindo, GS Baird, B Young, M Ryan, JA Jefferson, R Mehrotra, ...
Clinica Chimica Acta 520, 16-22, 2021
222021
APOL1 genotype-associated morphologic changes among patients with focal segmental glomerulosclerosis
J Zee, MT McNulty, JB Hodgin, O Zhdanova, S Hingorani, JA Jefferson, ...
Pediatric Nephrology 36, 2747-2757, 2021
62021
Steroid Minimization in Adults with Minimal Change Disease
A Koirala, JA Jefferson
Glomerular Diseases 1 (4), 237-249, 2021
12021
How safe is a native kidney biopsy?
A Koirala, JA Jefferson
Clinical Journal of the American Society of Nephrology 15 (11), 1541-1542, 2020
72020
Longitudinal changes in health-related quality of life in primary glomerular disease: results from the CureGN study
SL Murphy, JD Mahan, JP Troost, T Srivastava, AJ Kogon, Y Cai, ...
Kidney international reports 5 (10), 1679-1689, 2020
232020
The longitudinal relationship between patient-reported outcomes and clinical characteristics among patients with focal segmental glomerulosclerosis in the Nephrotic Syndrome …
JP Troost, A Waldo, NE Carlozzi, S Murphy, F Modersitzki, H Trachtman, ...
Clinical kidney journal 13 (4), 597-606, 2020
202020
Persistent Disease Activity in Patients With Long-Standing Glomerular Disease
E Delbarba, M Marasa, PA Canetta, SE Piva, D Chatterjee, BH Kil, X Mu, ...
Kidney international reports 5 (6), 860-871, 2020
2020
系统目前无法执行此操作,请稍后再试。
文章 1–20